Trump approves plan to fire FDA Commissioner Marty Makary, sources say
Anonymous Sourcing
How They Deceive You
Propaganda
Relies heavily on anonymous sources for its core claim while omitting Trump's public denial and broader context of conflicts, introducing minor framing bias.
Main Device
Anonymous Sourcing
The central claim of Trump approving a firing plan rests entirely on two unnamed sources and a senior HHS official, obscuring incentives and verifiability.
Archetype
Mainstream anti-Trump establishment
CBS News, rated Lean Left, prominently frames Trump administration internal conflicts without equivalent scrutiny of prior appointees or balancing denials.
This article tries to inform via standard anonymous scoops but deceives through omitted Trump denial and selective conflict framing that amplifies tensions.
Writer's Worldview
“Mainstream anti-Trump establishment”
3 findings · 2 omissions · 4 sources compared
What is your news hiding from you?
Same analysis. Any article. Completely free.
Narrative Analysis
Verdict: This CBS News scoop competently reports on reported Trump administration tensions over FDA Commissioner Marty Makary's future, drawing from anonymous sources echoed across outlets like WSJ and NYT. It's mostly fair but hedges less on one unverified internal claim and skips verifiable context like Trump's public denial.
Key Reporting Techniques
- Anonymous sourcing as core: The article's central claim—"Trump has approved a plan to fire" Makary—rests on two unnamed sources familiar with the discussions, plus a "senior HHS official" on internal support.
- > "Sources tell CBS News that President Trump has approved a plan to fire FDA Commissioner Marty Makary."
- This is standard for White House scoops (mirrored in WSJ, CNN, Reuters), but obscures source incentives, such as potential disgruntled aides.
- Caveats included: Article notes Trump "dodged questions" on the topic and flags Makary's short tenure (since April 2025), softening the sensational headline.
- Unverified internal dynamic: One claim stands out as less corroborated.
"Makary has a lot of support inside HHS, one senior HHS official said."
- No public evidence confirms broad HHS backing; other reports (e.g., Politico) indicate HHS leadership urged the ouster.
Verifiable Omissions and Impact
These gaps involve concrete facts reported elsewhere, potentially altering reader grasp of timeline and disputes:
- Trump's public denial: Trump dismissed firing reports in comments Friday evening (NYT, May 8), framing him as actively rebutting rather than just evading.
- Broader policy clashes: Tensions spanned mifepristone oversight, vaccine policies, and biotech drug denials—not just vaping regulations (NYT, WSJ, PBS, May 8).
- Why it matters: Narrows perceived motives to one issue, missing fuller causal chain verified in peer outlets.
No omissions of Makary's background (e.g., Johns Hopkins professor, bipartisan Senate confirmation March 2025) or achievements, which some coverage adds.
Author and Outlet Context
- Reporters: Ed O'Keefe (CBS senior White House correspondent, covered Trump/Biden fully) and Michael Kaplan (investigative unit, "60 Minutes" contributor) bring deep D.C. experience.
- CBS framing: Lean Left per AllSides, but story aligns with WSJ original—no unique spin. Article credits WSJ indirectly via shared details.
Coverage Across Outlets
Outlets converged on the core anon-sourced claim but varied in depth:
| Outlet | Key Diffs | Length/Tone |
|---|---|---|
| WSJ | Original reporter; bare-bones on "clashes," no policy details, Trump denial, or achievements. | Shortest, neutral-business. |
| NYT | Most context-rich: vaping/abortion/biotech clashes, Makary wins (food safety, approvals), Trump denial quote. | ~500 words, balanced. |
| CNN | Breaking-news urgency via "senior official"; skips policy, background, denial. | Brevity-focused. |
| Reuters | Wire-style facts, cites WSJ/sources; no extras. | Concisest, neutral. |
CBS sits mid-pack: more detail than WSJ/CNN/Reuters but less policy/denial context than NYT.
Bottom Line
Strengths: Timely, multi-sourced scoop verified outlet-wide; experienced bylines add credibility; caveats temper drama. Weaknesses: Heavy anon reliance (industry norm) plus one unbacked HHS claim and omitted facts (Trump rebuttal, full clashes) slightly tilt toward tension without full balance. Solid journalism overall—readers get the headline event, but cross-checking peers fills gaps.
Further Reading
Neutral Rewrite
Here's how this article reads with loaded language removed and missing context included.
Sources: Trump Approves Plan to Dismiss FDA Commissioner Marty Makary
By Kristin Brown, Ed O'Keefe and Michael Kaplan
*Senior White House and Political Correspondent, Reporter and Producer*
Updated: May 11, 2026 / 1:20 PM EDT
/ CBS News
Washington — Two sources familiar with the matter told CBS News that President Trump has approved a plan to dismiss Food and Drug Administration Commissioner Marty Makary. The timing of any potential termination remains unclear, and the president could alter the decision.
Makary has not been notified of any dismissal, according to a senior Health and Human Services official. That official also said Makary retains significant support within HHS.
On Friday, Trump dismissed reports about Makary's potential removal when questioned publicly. He did not address the matter further.
Makary was absent Monday from an Oval Office appearance with other senior federal public health officials during President Trump's comments on administration initiatives related to maternal health. A spokesperson for the Senate Appropriations Committee told CBS News on Monday that Makary remains scheduled to testify before the panel on Wednesday.
Makary, a British-American surgeon, was confirmed as FDA commissioner in March 2025. The Wall Street Journal first reported that Trump had approved a plan to remove him.
Reports have described tensions between Makary and Trump administration officials over the FDA's policy directions. According to the Journal, the FDA approved flavored e-cigarettes on May 6, following what sources described as pressure from Trump after Makary had declined to do so. The Journal cited advisers who informed the president that Makary was impeding vaping-related priorities and posed challenges for the administration.
Additional reports have pointed to disagreements involving FDA oversight of mifepristone, vaccine policies and approvals or denials of certain biotech drugs as factors in the reported conflicts.
*Alan He, Kathryn Watson and Dr. Céline Gounder contributed to this report.*
*(Word count: 408)*
Investigation Log · 42 steps
Starting investigation...
Investigating CBS News
Investigating Ed O'Keefe
Investigating Marty Makary
Searching for ""Wall Street Journal" "Trump" "fire" "FDA" "Makary""
Verify if WSJ first reported Trump approving plan to fire Makary
Searching for "FDA approves flavored e-cigarettes May 6 2026 Trump pressure Makary"
Verify claim about FDA approving flavored vapes on May 6 after Trump pressure on Makary
Searching for "Trump approves plan to fire FDA Commissioner Marty Makary sources"
See if other outlets confirm the main claim of Trump approving firing plan
Source: CBS News
CBS News is the news division of the American broadcaster CBS, founded in 1927 and headquartered in New York City. It is one of the 'big three' U.S. broadcast news networks alongside ABC News and NBC News. No specific fact-checking scores, ratings, or credibility metrics are mentioned in the provided results.
Source: Ed O'Keefe
Ed O'Keefe is a veteran journalist with nearly 13 years at The Washington Post (2005-2018), where he served as home page editor, produced for Washington Post Radio, hosted 'The Post Politics Podcast,' and covered federal agencies, Congress, the 2008 and 2016 presidential campaigns, and part of the 2011 Iraq war. Since joining CBS News full-time in 2018 as senior White House and political correspondent, he has led coverage of the 2020 and 2024 elections, Biden's presidency, Trump's term, the Jan. 6, 2021 Capitol assault, midterms, and events like the Kavanaugh confirmation and 2019 government shutdown. He has appeared as a guest or panelist on diverse outlets including BBC, CBS, CNN, Fox News, France 24, MSNBC, NPR, PBS, and Sirius/XM.
Source: Marty Makary
Marty Makary is a British-American surgeon specializing in abdominal surgery, surgical oncology, and gastrointestinal laparoscopic surgery, who served as a professor and chief of Islet Transplant Surgery at Johns Hopkins until becoming Professor Emeritus. He was confirmed as the 27th FDA Commissioner on March 25, 2025, by a bipartisan U.S. Senate vote after nomination by President-elect Donald Trump, assuming office on April 1, 2025. His innovations include pioneering the first laparoscopic Whipple and Frey’s procedures and leading the WHO Surgery Checklist development.
Searching for "CBS News AllSides media bias rating"
Get specific bias rating for CBS News
Searching for ""Trump" "fire" "Makary" site:foxnews.com OR site:newsmax.com OR site:breitbart.com"
See how right-leaning outlets covered the story for opposite bias perspective
Searching for "Marty Makary Trump FDA conflict vaping reasons"
Find missing context on why Trump wants to fire Makary, any other tensions
Comparing coverage of "Trump approves plan to fire FDA Commissioner Marty Makary"
Searching for "Marty Makary support inside HHS Trump firing"
Verify HHS support claim and if Makary was fired
Coverage comparison completed
Source Credibility
CBS News rated Lean Left by AllSides, yet frames Trump admin internal conflict prominently without equivalent scrutiny of prior appointees.
Lean Left outlets may amplify negative Trump stories; lack of right-leaning coverage suggests story downplayed by pro-Trump sources, creating asymmetric visibility.
Source Credibility
Core claim ("Trump has approved a plan to fire") relies on two unnamed "sources"; HHS support from unnamed "senior official."
Orphan quotes obscure source motives/reliability; reader can't assess if sources are disgruntled staff or neutral insiders.
unverified_claim
"Makary has a lot of support inside HHS" per senior HHS official.
Potentially misleads on internal dynamics; searches show HHS leadership pressured for ouster (Politico), no confirming evidence of broad support.
Missing Context
Trump dismissed reports of firing Makary in public comments Friday evening.
Balances "dodged questions" framing; shows Trump actively rebutted, not just evaded.
Missing Context
Conflicts included mifepristone oversight, vaccine policies, biotech drug denials beyond just vaping.
Provides fuller causal context for tensions; article reduces to vaping, potentially simplifying motives.
**Investigation notes:** CBS News rated Lean Left by AllSides; authors credible with no noted biases; Makary Trump appointee confirmed bipartisan in 2025. Main claim (Trump approved firing plan) confirmed by WSJ (original), Reuters, NYT, CNN. Vaping approval May 6 verified, with WSJ reporting Trump pressure. No right-leaning coverage found (Fox/Newsmax/Breitbart). HHS "support" claim unverified/contradicted by reports of HHS leadership pushing ouster (Politico). Other coverage (NYT) adds Makary achievements/clashes (mifepristone, vaccines) and Trump dismissal of reports.
Writing analysis narrative
Writing neutral rewrite
Neutral rewrite ready
Analysis narrative ready
Writing verdict summary
Investigation complete. Preparing report...
The Compass
You see how this outlet sees the world.
How do you see it? Find your political shape in a few minutes.
Take the testOr check your own article